EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations between pathological features and risk of metachronous colorectal cancer

Ye Zhang iD, Aung Ko Win, Enes Makalic, Daniel D Buchanan iD, Rish K Pai, Amanda I Phipps, Christophe Rosty, Alex Boussioutas, Amalia Karahalios, Mark A Jenkins

International Journal of Cancer · 2024

DOI: 10.1002/ijc.34979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Ye Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Neoplasms, Second Primary, Colorectal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council (NHMRC), Surveillance, Epidemiology, and End Results (SEER) Program, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Survivors of colorectal cancer (CRC) are at risk of developing another primary colorectal cancer ‐ metachronous CRC. Understanding which pathological features of the first tumour are associated with risk of metachronous CRC might help tailor existing surveillance guidelines. Population‐based CRC cases were recruited from the United States, Canada and Australia between 1997 and 2012 and followed prospectively until 2022 by the Colon Cancer Family Registry. Metachronous CRC was defined as a new primary CRC diagnosed at least 1 year after the initial CRC. Those with the genetic cancer predisposition Lynch syndrome or MUTYH mutation carriers were excluded. Cox regression models were fitted to estimate hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) for the associations. Of 6085 CRC cases, 138 (2.3%) were diagnosed with a metachronous CRC over a median follow‐up time of 12 years (incidence: 2.0 per 1000 person‐years). CRC cases with a synchronous CRC were 3.4‐fold more likely to develop a metachronous CRC (adjusted HR: 3.36, 95% CI: 1.89–5.98) than those without a synchronous tumour. CRC cases with MMR‐deficient tumours had a 72% increased risk of metachronous CRC (adjusted HR: 1.72, 95% CI: 1.11–2.64) compared to those with MMR‐proficient tumours. Compared to cases who had an adenocarcinoma histologic type, those with an undifferentiated histologic type were 77% less likely to develop a metachronous CRC (adjusted HR: 0.23, 95% CI: 0.06–0.94). Existing surveillance guidelines for CRC survivors could be updated to include increased surveillance for those whose first CRC was diagnosed with a synchronous CRC or was MMR‐deficient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Second PrimaryColorectal NeoplasmsHumansMaleFemaleMiddle AgedAgedAustraliaCanadaRisk FactorsAdultProspective StudiesIncidenceUnited StatesRegistriesProportional Hazards Models

Stichwörter der Autor:innen

colorectal cancermetachronouspathologyrisk factor

Autor:innen und Institutionen

  • Center for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
  • University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.
  • Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Department of Pathology and Laboratory Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
  • Department of Epidemiology, University of Washington, Seattle, Washington, USA.
  • Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.

ORCID-Profile: Ye Zhang, Daniel D Buchanan

Förderung

  • National Health and Medical Research Council (NHMRC)
  • Surveillance, Epidemiology, and End Results (SEER) Program
  • NCI NIH HHS
  • Victoria Cancer Registry (Australia)
  • China Scholarship Council
  • Ontario Cancer Registry (Canada)
  • National Cancer Institute (NCI)
  • University of Melbourne

Zitieren

APA

Zhang, Y., Win, A. K., Makalic, E., Buchanan, D. D., Pai, R. K., Phipps, A. I., Rosty, C., Boussioutas, A., Karahalios, A., & Jenkins, M. A. (2024). Associations between pathological features and risk of metachronous colorectal cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.34979

Vancouver

Zhang Y, Win AK, Makalic E, Buchanan DD, Pai RK, Phipps AI, et al. Associations between pathological features and risk of metachronous colorectal cancer. International Journal of Cancer. 2024. doi:10.1002/ijc.34979

BibTeX
@article{Zhang2024,
  author = {Zhang, Ye and Win, Aung Ko and Makalic, Enes and Buchanan, Daniel D and Pai, Rish K and Phipps, Amanda I and Rosty, Christophe and Boussioutas, Alex and Karahalios, Amalia and Jenkins, Mark A},
  title = {Associations between pathological features and risk of metachronous colorectal cancer},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.34979}
}
Kostenlos starten →